TRIM32

Across TCGA pan-cancer cohorts, TRIM32 mass-spec protein differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of TRIM32’s most consistent transcriptional readouts.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where TRIM32 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types TRIM32 is over-expressed in tumor, although a few such as PDAC and HNSC show the opposite, repressed pattern.

PDAC, HNSC, and CCRCC are the cancer types where TRIM32 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TRIM32 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PDAC	All	II,III,IV	−0.199	<.001	8	view →
HNSC	Male	II,III,IV	−0.161	.001	6	view →
CCRCC	All	All	+0.137	<.001	6	view →
LUAD	Female	All	+0.093	.007	2	view →
COAD	Female	IV	−0.765	.029	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

TRIM32–PDAC

Open the PDAC breakdown →